Advanced Biomed Inc. (ADVB): Operating Income

Annual figures by period end, from SEC filings.

-$6.23M

Year ended 2026-06-30

2025-06-30 Operating Income (USD) 2026-06-30

Period ended	Operating Income	Change YoY	Source filing
2026-06-30	-$6.23M	n/m	2026-10-13, From 2025-07-01
2025-06-30	-$1.09M	n/a	2026-10-13, From 2024-07-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Advanced Biomed Inc. (ADVB)	2026-06-30	-$6.23M	n/m
YD Bio Ltd (YDES)	2025-12-31	-$5.27M	n/m
Aclarion, Inc. (ACON)	2025-12-31	-$7.05M	n/m
BioNexus Gene Lab Corp (BGLC)	2025-12-31	-$2.97M	n/m
CapForce Inc. (CFOR)	2025-12-31	$24.03M	n/m
First Choice Healthcare Solutions, Inc. (FCHS)	2025-12-31	-$2.67M	n/m
American Shared Hospital Services (AMS)	2025-12-31	-$3.59M	n/m
Exagen Inc. (XGN)	2025-12-31	-$14.07M	n/m
Biodesix Inc (BDSX)	2025-12-31	-$27.87M	n/m

Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗